Local News

Biolex Reports Progress in Hepatitis C Treatment

Posted April 28, 2006

— Biolex Therapeutics

reported positive results in a Phase I trial of a proposed drug to treat Hepatitis C.

Biolex is developing the drug Locteron along with OctoPlus, a firm based in the Netherlands.

The drug is centered around a compound, BLX-883, developed by Biolex and a controlled-release drug delivery system designed by OctoPlus.

The two companies plan to launch Phase II clinical testing in the second half of this year.


Please with your WRAL.com account to comment on this story. You also will need a Facebook account to comment.

Oldest First
View all